Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.4.0.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Revenues, net:    
Product $ 3,546,683 $ 1,575,367
Recurring 1,077,423 999,179
Total Net Revenues 4,624,106 2,574,546
Cost of Sales:    
Product 1,787,454 1,089,824
Recurring 278,035 238,264
Total Cost of Sales 2,065,489 1,328,088
Gross Profit 2,558,617 1,246,458
Operating Expenses:    
Research and development 426,814 359,529
Selling, general and administrative 1,874,714 1,489,464
Depreciation and amortization 68,834 69,302
Total Operating Expense 2,370,362 1,918,295
Income (Loss) from Operations 188,255 (671,837)
Other (Expenses) Income:    
Interest income (expense), net (16,196) (20,054)
Total Other (Expense) Income (16,196) (20,054)
Income (Loss) Before Provision for Income Taxes 172,059 (691,891)
Provision for Income Taxes 51,937 52,187
Net Income (Loss) 120,122 (744,078)
Accretion of preferred dividends and discount 0 (18,253)
Net Income (Loss) attributable to common stockholders $ 120,122 $ (762,331)
Net loss per common share:    
Net income (loss) attributable to common stockholders per common share - basic $ 0.00 $ (.01)
Net income (loss) attributable to common stockholders per common share - diluted $ 0.00 $ (.01)
Weighted Average Common Shares Outstanding - basic 127,054,848 125,035,612
Weighted Average Common Shares Outstanding - diluted 129,335,871 125,035,612